BioSpace News Archive

Eagle Pharmaceuticals, Inc. announced that the Company has resubmitted its New Drug Application for RYANODEX® for the treatment of exertional heat stroke, in addition to body cooling, to the U.S. Food and Drug Administration.

LHC Group, Inc. announced that the Company is presenting at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 13, 2020.

Omnipresence Platform Provides Biopharmaceutical Companies Advanced Analytics, AI and Cloud Innovations Powered by Microsoft

Intec Pharma Ltd. provides a business and clinical update on its development programs with the Company’s proprietary oral drug delivery system, the Accordion Pill® platform, in a Letter to Shareholders.

Encouraging preliminary COM701 Phase 1 clinical data presented at SITC 2019 demonstrated initial signs of anti-tumor activity in highly refractory patient population

Healios K.K. Japan’s leading clinical stage biotechnology company harnessing the potential of stem cells for regenerative therapies announces that its Chairman and Chief Executive Officer, Hardy TS Kagimoto, MD, will provide a strategic overview and company update at the 38th Annual J.P. Morgan Healthcare Conference.

Approximately 25% decrease in total bone lesions (both new and existing) driven by nearly 90% reduction in formation of new lesions in patients with fibrodysplasia ossificans progressiva (FOP)

Contextual Genomics, a leading cancer genomics company, announced that it has named Brady Davis to its executive team.

Data from MEDALIST showed significant clinical benefit of Reblozyl in treating anemia in adults with myelodysplastic syndromes

F-star Therapeutics announces the appointments of Dr. Edward Benz and Mr. Geoff Race to its Board of Directors, further strengthening the depth and breadth of its clinical and industry expertise.